Disease-Specific Transgene Product

Disease-specific transgene products refer to proteins that are either missing, dysfunctional, or mutated in a particular genetic disorder. In the context of gene therapy, these products are the specific molecules (often proteins) encoded by the therapeutic transgene introduced into patient cells to restore normal function. Examples include SMN1 for spinal muscular atrophy (SMA) and MECP2 for Rett syndrome. Restoration of these proteins via gene therapy has shown promise in preclinical models and early clinical trials, with ongoing research focused on optimizing delivery methods, dosing, safety profiles, and long-term efficacy.

Gene replacement; protein restoration